🔎 Trials Near Me

Home › Kakulangan sa Alpha-1 Antitrypsin › South Carolina

Pag-aaral pangklinika para sa Kakulangan sa Alpha-1 Antitrypsin sa South Carolina

6 pag-aaral para sa Kakulangan sa Alpha-1 Antitrypsin ang naghahanap ng mga kalahok sa mga site sa South Carolina.

Mga Lungsod sa South Carolina

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

  • Clinical Study Center, Charleston
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06389877

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

  • Clinical Study Center, Charleston
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07227207

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 101, Charleston
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07555483

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

  • University of South Carolina, Charleston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06512454

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

  • Medical University of South Carolina, Charleston
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 13, 2026 · NCT05677971

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

  • Medical University of South Carolina, Charleston
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 22, 2025 · NCT06049082

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.